Journal for ImmunoTherapy of Cancer (Nov 2023)
657 A combination treatment of bone marrow-derived CD141+dendritic cells and PD1/PD-L1 inhibitors for effective immunotherapy for solid tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)